Ratings Acen Corporation

Equities

ACEN

PHY1001H1024

End-of-day quote Philippines S.E. 06:00:00 2024-04-24 pm EDT 5-day change 1st Jan Change
3.68 PHP +7.60% Intraday chart for Acen Corporation +15.00% -15.98%

Summary

  • From a short-term investment perspective, the company presents a deteriorated fundamental situation

Strengths

  • Before interest, taxes, depreciation and amortization, the company's margins are particularly high.
  • Margins returned by the company are among the highest on the stock exchange list. Its core activity clears big profits.
  • The company appears to be poorly valued given its net asset value.
  • The average target price set by analysts covering the stock is above current prices and offers a tremendous appreciation potential.

Weaknesses

  • One of the major weak points of the company is its financial situation.
  • Based on current prices, the company has particularly high valuation levels.
  • For the last four months, EPS estimates made by Standard & Poor's analysts have been revised downwards.
  • The overall consensus opinion of analysts has deteriorated sharply over the past four months.
  • Prospects from analysts covering the stock are not consistent. Such dispersed sales estimates confirm the poor visibility into the group's activity.
  • The price targets of various analysts who make up the consensus differ significantly. This reflects different assessments and/or a difficulty in valuing the company.

Ratings chart - Surperformance

Chart ESG Refinitiv

Sector: Independent Power Producers

1st Jan change Capi. Investor Rating ESG Refinitiv
-21.92% 2.35B
B-
+13.08% 40.92B
B
+12.84% 27.61B -
C
+19.35% 16.18B
B-
+26.60% 12.09B
B
+24.78% 8.94B
C+
+23.58% 6.34B
C+
+50.92% 5.68B
D-
+32.39% 5.04B
C
-7.74% 3.87B -
C
Investor Rating
Trading Rating
ESG Refinitiv

Financials

Sales growth
Earnings Growth
EBITDA / Sales
Profitability
Finances

Valuation

P/E ratio
EV / Sales
Price to Book
Price to Free Cash Flow
-
Yield

Momentum

1 year Revenue revision
4 months Revenue revision
7 days Revenue revision
1 year EPS revision
4 months EPS revision

Consensus

Analyst Opinion
Potential Price Target
4m Target Price Revision
4m Revision of opinion
12m Revision of opinion

Business Predictability

Analyst Coverage
Divergence of Estimates
Divergence of analysts' opinions
Divergence of Target Price
Earnings quality

Environment

Emissions
Innovation
Use of resources

Social

Social commitment
Human Rights
Product liability
Human Resources

Governance

CSR Strategy
Management
Shareholders

Controversy

Controversy
  1. Stock Market
  2. Equities
  3. ACEN Stock
  4. Ratings Acen Corporation